ASHLEY POIRIER: Open Payments
NPI 1548798663 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 20 payments from 11 companies in 2025. Trend: 2023 $448 · 2024 $674 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 3 | $326 |
| Amgen Inc. | 2 | $244 |
| Gilead Sciences, Inc. | 5 | $140 |
| Axsome Therapeutics, Inc. | 2 | $128 |
| ABBVIE INC. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| Astellas Pharma US Inc | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $117 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
Products named: ULTOMIRIS, Auvelity, EVENITY, VRAYLAR, EPIDIOLEX, Veozah, UZEDY, TEPEZZA.
Industry payments across MI — which companies pay providers there.
